Literature DB >> 22734839

Bioactivation of fluorinated 2-aryl-benzothiazole antitumor molecules by human cytochrome P450s 1A1 and 2W1 and deactivation by cytochrome P450 2S1.

Kai Wang1, F Peter Guengerich.   

Abstract

Both 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (5F 203) and 5-fluoro-2-(3,4-dimethoxyphenyl)-benzothiazole (GW 610) contain the benzothiazole pharmacophore and possess potent and selective in vitro antitumor properties. Prior studies suggested the involvement of cytochrome P450 (P450) 1A1 and 2W1-mediated bioactivation in the antitumor activities and P450 2S1-mediated deactivation of 5F 203 and GW 610. In the present study, the biotransformation pathways of 5F 203 and GW 610 by P450s 1A1, 2W1, and 2S1 were investigated, and the catalytic parameters of P450 1A1- and 2W1-catalyzed oxidation were determined in steady-state kinetic studies. The oxidations of 5F 203 catalyzed by P450s 1A1 and 2W1 yielded different products, and the formation of a hydroxylamine was observed for the first time in the latter process. Liquid chromatography-mass spectrometry (LC-MS) analysis with the synthetic hydroxylamine and also a P450 2W1/5F 203 incubation mixture indicated the formation of dGuo adduct via a putative nitrenium intermediate. P450 2W1-catalyzed oxidation of GW 610 was 5-fold more efficient than the P450 1A1-catalyzed reaction. GW 610 underwent a two-step oxidation process catalyzed by P450 1A1 or 2W1: a regiospecific O-demethylation and a further hydroxylation. Glutathione (GSH) conjugates of 5F 203 and GW 610, presumably through a quninoneimine and a 1,2-quinone intermediate, respectively, were detected. These results demonstrate that human P450s 1A1 and 2W1 mediate 5F 203 and GW 610 bioactivation to reactive intermediates and lead to GSH conjugates and a dGuo adduct, which may account for the antitumor activities of 5F 203 and GW 610 and also be involved in cell toxicity. P450 2S1 can catalyze the reduction of the hydroxylamine to the amine 5F 203 under anaerobic conditions and, to a lesser extent, under aerobic conditions, thus attenuating the anticancer activity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22734839      PMCID: PMC3850770          DOI: 10.1021/tx3001994

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  29 in total

1.  Drug metabolism by Escherichia coli expressing human cytochromes P450.

Authors:  A Parikh; E M Gillam; F P Guengerich
Journal:  Nat Biotechnol       Date:  1997-08       Impact factor: 54.908

Review 2.  Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity.

Authors:  F P Guengerich
Journal:  Chem Res Toxicol       Date:  2001-06       Impact factor: 3.739

3.  Antitumor benzothiazoles. 14. Synthesis and in vitro biological properties of fluorinated 2-(4-aminophenyl)benzothiazoles.

Authors:  I Hutchinson; M S Chua; H L Browne; V Trapani; T D Bradshaw; A D Westwell; M F Stevens
Journal:  J Med Chem       Date:  2001-04-26       Impact factor: 7.446

4.  Induction and developmental expression of cytochrome P450IA1 messenger RNA in rat and human tissues: detection by the polymerase chain reaction.

Authors:  C J Omiecinski; C A Redlich; P Costa
Journal:  Cancer Res       Date:  1990-07-15       Impact factor: 12.701

5.  Role of Cyp1A1 in modulation of antitumor properties of the novel agent 2-(4-amino-3-methylphenyl)benzothiazole (DF 203, NSC 674495) in human breast cancer cells.

Authors:  M S Chua; E Kashiyama; T D Bradshaw; S F Stinson; E Brantley; E A Sausville; M F Stevens
Journal:  Cancer Res       Date:  2000-09-15       Impact factor: 12.701

6.  Formation and reduction of aryl and heterocyclic nitroso compounds and significance in the flux of hydroxylamines.

Authors:  Donghak Kim; Fred F Kadlubar; Candee H Teitel; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2004-04       Impact factor: 3.739

7.  Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon.

Authors:  R J Turesky; N P Lang; M A Butler; C H Teitel; F F Kadlubar
Journal:  Carcinogenesis       Date:  1991-10       Impact factor: 4.944

8.  Mechanism of C8 alkylation of guanine residues by activated arylamines: evidence for initial adduct formation at the N7 position.

Authors:  W G Humphreys; F F Kadlubar; F P Guengerich
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

9.  DNA damage and cell cycle arrest induced by 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (5F 203, NSC 703786) is attenuated in aryl hydrocarbon receptor deficient MCF-7 cells.

Authors:  V Trapani; V Patel; C-O Leong; H P Ciolino; G C Yeh; C Hose; J B Trepel; M F G Stevens; E A Sausville; A I Loaiza-Pérez
Journal:  Br J Cancer       Date:  2003-02-24       Impact factor: 7.640

10.  Four forms of cytochrome P-450 in human fetal liver: purification and their capacity to activate promutagens.

Authors:  M Kitada; M Taneda; K Itahashi; T Kamataki
Journal:  Jpn J Cancer Res       Date:  1991-04
View more
  19 in total

1.  A synthesis of functionalized arylthio-acrylates, benzo[b][1,4]thiazines and benzo[4,5]thiazolo[3,2-a]azepines from 2-methylbenzothiazole and acetylenic esters in aqueous media.

Authors:  Issa Yavari; Kiyana Ghafouri; Nooshin Zahedi; Mohammad Reza Halvagar
Journal:  Mol Divers       Date:  2017-06-20       Impact factor: 2.943

2.  Aryl Hydrocarbon Receptor Ligand 5F 203 Induces Oxidative Stress That Triggers DNA Damage in Human Breast Cancer Cells.

Authors:  Lancelot S McLean; Cheri N Watkins; Petreena Campbell; Dain Zylstra; Leah Rowland; Louisa H Amis; Lia Scott; Crystal E Babb; W Joel Livingston; Agus Darwanto; Willie L Davis; Maheswari Senthil; Lawrence C Sowers; Eileen Brantley
Journal:  Chem Res Toxicol       Date:  2015-04-01       Impact factor: 3.739

3.  A Role for the Orphan Human Cytochrome P450 2S1 in Polyunsaturated Fatty Acid ω-1 Hydroxylation Using an Untargeted Metabolomic Approach.

Authors:  Mostafa I Fekry; Yi Xiao; Jeannette Zinggeler Berg; F Peter Guengerich
Journal:  Drug Metab Dispos       Date:  2019-09-11       Impact factor: 3.922

4.  Reduction of aromatic and heterocyclic aromatic N-hydroxylamines by human cytochrome P450 2S1.

Authors:  Kai Wang; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2013-05-29       Impact factor: 3.739

5.  Catalytic Activities of Tumor-Specific Human Cytochrome P450 CYP2W1 Toward Endogenous Substrates.

Authors:  Yan Zhao; Debin Wan; Jun Yang; Bruce D Hammock; Paul R Ortiz de Montellano
Journal:  Drug Metab Dispos       Date:  2016-03-02       Impact factor: 3.922

Review 6.  Cytochrome P450-activated prodrugs.

Authors:  Paul R Ortiz de Montellano
Journal:  Future Med Chem       Date:  2013-02       Impact factor: 3.808

7.  Chemistry of ring-substituted 4-(benzothiazol-2-yl)phenylnitrenium ions from antitumor 2-(4-aminophenyl)benzothiazoles.

Authors:  Yang Zhang; Mrinal Chakraborty; Christian G Cerda-Smith; Ryan N Bratton; Natalie E Maurer; Ethan M Senser; Michael Novak
Journal:  J Org Chem       Date:  2013-07-01       Impact factor: 4.354

8.  Cytochrome P450 Binding and Bioactivation of Tumor-Targeted Duocarmycin Agents.

Authors:  Aaron G Bart; Goreti Morais; Venu R Vangala; Paul M Loadman; Klaus Pors; Emily E Scott
Journal:  Drug Metab Dispos       Date:  2021-10-04       Impact factor: 3.922

9.  Development of novel apoferritin formulations for antitumour benzothiazoles.

Authors:  Alastair F Breen; Geoffrey Wells; Lyudmila Turyanska; Tracey D Bradshaw
Journal:  Cancer Rep (Hoboken)       Date:  2019-01-16

Review 10.  Unusual cytochrome p450 enzymes and reactions.

Authors:  F Peter Guengerich; Andrew W Munro
Journal:  J Biol Chem       Date:  2013-04-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.